1. 466. OUTCOME OF NIVOLUMAB FOR UNRESECTABLE ADVANCED OR RECURRENT ESOPHAGEAL CANCER IN OUR INSTITUTION. (24th September 2022) Authors: Tabuchi, Satoshi; Takano, Yuki; Ochiai, Shigeto; Gunji, Takahiro; Kobayashi, Toshimichi; Suzumura, Hirofumi; Shigoka, Masatoshi; Chiba, Naokazu; Hidaka, Eiji; Kawachi, Shigeyuki Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗